baber/WOPTO huggingface dataset:
Patent DK-176055-B1 (DK)
Inventor: SPAETE RICHARD R
IPC: C07K16/00
Filed: 1990-07-27
Granted: 2006-02-27
Abstract: The present invention provides recombinant polypeptides derived from CMV glycoprotein gB and truncated fragments thereof which contain at least one epitope which is immunologically identifiable with one encoded by the CMV genome. The complete characterization of the gB protein, including the identity of glycoprotein gp55, permits the production of polypeptides which are useful as standards or reagents in diagnostic tests and/or as components of vaccines. This invention provides recombinant polypeptides and recombinant polynucleotides encoding these polypeptides wherein a neutralizing epitope of gB is localized within gp55.
Patent DK-168039-B1 (DK)
Inventor: BLONDE JEAN-MARC
IPC: E05D15/10
Filed: 1989-09-13
Granted: 1994-01-24
Abstract: In this sliding door (8) a door wing (10) lying flush, in the closed position, with a door frame (9) is moved from the closed position into the open position by means of a linear pushing movement. The door wing (10) is hung on an upper telescopic arm (16) and hung on a lever (22) running in parallel and is guided on the lower edge of a lower telescopic arm. The lever (22) connects to a roller (21) which runs on the upper telescopic arm (16) and which carries an ancon moved by a toothed belt (15). The telescopic arm (16) consists of a first tube (18) arranged on the vehicle body (2), into which tube a second tube (19) and a third tube (20) are pushed. The second tube (19) and the third tube (20) are moved under the control of the toothed belt (15) by means of a bolt arranged on the ancon. Safety switches (13) monitor the closed position of the door wing (10). <IMAGE>
Patent HU-226897-B1 (HU)
Title: Radiopharmacological compositions and process for producing and administering them
Inventor: FRANK KEITH R
IPC: A61P35/00
Filed: 1991-06-17
Abstract: Radiopharmaceutical formulations for complexes comprising at least one radionuclide complexed with a ligand, or its physiologically-acceptable salts thereof, especially <1><5><3>samarium-ethylenediaminetetramethylenephosphonic acid, which optionaily contains a divalent metal ion, e.g. calcium, and is frozen, thawed, and then administered by injection. Alternatively, the radiopharmaceutical formulations must contain the divalent metal and are frozen only if the time before administration is sufficiently long to cause concern for radiolysis of the ligand.
Patent IE-37335-B1 (IE)
Title: Toothpastes
IPC: A61K8/21
Filed: 1973-07-14
Abstract: Transparent dentifrice formulations including a fluorine containing ingredient, preferably stannous fluoride, are disclosed. The fluorine ingredient is incorporated in aesthetically pleasing speckles that are uniformly dispersed throughout the clear dentifrice.
Patent IE-39399-B1 (IE)
Title: Thioxanthene derivative
IPC: C07D335/16
Filed: 1974-05-29
Abstract: 1469108 Thiaxanthene derivative KEFALAS AS 4 June 1974 [25 June 1973] 30152/73 Heading C2C The invention comprises the alpha-isomer of 2 - chloro - 9 - [3<SP>1</SP> - (N<SP>1</SP> - 2 - hydroxyethylpiperazino)propylidene]thiaxanthene (I), m.p. 84- 85 C., its esters with C 1-16 aliphatic carboxylic acids, and acid addition salts of these compounds with pharmaceutically acceptable acids. (I) is prepared by removing the major part of the beta-isomer from a 30-35% alpha/70-65% beta isomer mixture by crystallization from an organic solvent, evaporating the mother-liquor, benzoylating the residue, crystallizing the (I)- benzoate from an organic solvent, saponifying or reducing the (I)-benzoate alpha-isomer thus obtained, and optionally acylating (I) to give an ester thereof. Therapeutic compositions for treating physiological-psychological abnormalities including psychotic disorders comprise I (or its said esters or salts), and may be administered orally, parenterally or rectally.
[GB1469108A]
Patent IE-37983-B1 (IE)
Title: Composite structures for furniture shelving partition walls or the like
IPC: A47B96/00
Filed: 1973-08-08
Abstract: 1447057 Structural joints for furniture &c. R VINCENS 7 Aug 1973 [8 Aug 1972 and 26 Jan 1973] 37382/73 Heading F2M [Also in Division E1-E2] In a building structure comprising at least one elongate support 50, Fig. 1, having a longitudinal channel 2 with an undercut rebate 3 and wherein the support receives a series of modular bridge or transverse members 150, Fig. 4, which are mounted longitudinally therein each member 150 comprises a rigid body 75 and at least two opposed side pillors 70 at least one of which is provided with at least one sharp edged lug 68 formed by a projection cut from that pillar, the connection between the members 50, 150 is such that the lugs of the pillars are concealed whilst other parts of the pillar frictionally engage the support 50. In a modification, the bridge member 152, Fig. 9, comprises a rectangular deck 76 having three rectangular basins 200 with slots 230 adapted to locate cross-bracing flanges (300-Fig. 10, not shown). The deck 76 is also provided with a locking catch 240, re-inforcing ribs 250, 251 and pillars 70 which in turn have flanks 81 profiled as shown and furnished with locking spurs 92 for fuller details of which Figs. 13, 15, 16 and 17 (not shown), should be referred to. Two units 152 may be interconnected by a member 360 having internal flanges 362, 363. For numerous modifications, materials employed, dimensions, application to the furniture art, joint details the Specification and remaining drawings, (not shown) should be referred to.
[GB1447057A]
Patent IE-39741-B1 (IE)
Title: Phenyl-benzoig acid deritavies
IPC: C07C313/00
Filed: 1974-08-19
Abstract: 1434405 Phenyl-benzoic acids LEO PHARMACEUTICAL PRODUCTS Ltd AS 21 Aug 1974 [6 Sept 1973] 42050/73 Heading C2C [Also in Division A5] The invention comprises novel therapeutic compounds (I) in which R 1 represents an optionally substituted, straight or branched C 1 -C 6 alkyl, alkenyl or alkynyl radical, or a C 1 -C 3 alkyl radical substituted with phenyl, halophenyl, trifluoromethylphenyl, (C 1 to C 6 alkoxy)phenyl, or with a 5-membered or 6-membered heterocyclic ring containing not more than two heteroatoms selected from oxygen, sulphur and nitrogen; Ar stands for an optionally substituted phenyl radical; Y stands for O, S, NH or a CH 2 radical; and YR 1 is placed in the 2- or 3- position with respect to the -COOH group; and pharmaceutically acceptable, non-toxic salts and esters thereof. They are made by standard methods and many intermediates and starting materials are also prepared.
[GB1434405A]
Patent IE-62302-B1 (IE)
Title: Controlled release implants for administration of recombinant growth hormones
Inventor: JANSKI ALVIN M
IPC: A61K9/22
Filed: 1986-07-14
Abstract: The present invention provides improved controlled release implants for subcutaneous administration to an animal of a growth promoting amount of a recombinant protein having growth hormone activity, characterised in that said protein is present in a form having a salt content of less than 5% by weight based on the weight of said protein.
Patent IE-64077-B1 (IE)
Title: Water treatment process
Inventor: BIRCHALL JAMES DEREK
IPC: C02F1/58
Filed: 1990-06-13
Abstract: Acid water containing toxic levels (> 0.1 ppm) of aluminium is treated to dissolve therein both silicate ions in an amount to create a solution containing at least 40, preferably at least 100, micromoles per litre of silicon and a silicon:aluminium ratio (based on metals) of at least about 6:1 and preferably 10:1 in the water to form a non-toxic complex with aluminium and alkali or alkali metal ions to increase the pH of the water. The preferred treatment agent is a hydraulic calcium silicate, in the form of cement clinker, optionally silicate-enriched with a soluble silicate.
Patent IE-49236-B1 (IE)
Title: Fuels and heating oils,a process for their preparation and their use
IPC: C10L1/32
Filed: 1979-12-14
Abstract: Fuels and heating oils containing hydrocarbons, water and emulsifiers are disclosed wherein the emulsifier is a non-ionic emulsifier and the non-ionic emulsifier is one which contains less than 1,000 ppm of salt constituents and less than 1 percent by weight of polyalkylene glycol ether constituents.
Patent IE-42614-B1 (IE)
Title: Materials and processes for flotation of mineral substances
IPC: B03D1/01
Filed: 1975-11-10
Abstract: 1487411 Froth flotation ALLIED COLLOIDS Ltd 14 Nov 1975 [19 Nov 1974] 49981/74 Heading B2H Pyrites, pyrrhotite, and/or sphalerite are depressed during froth flotation by an amine in which at least 20% of the amine groups are tertiary amine groups, with quaternary amine groups absent or present to a number less than one third that of the tertiary amine groups. The depressant may be monomeric e.g. a vinyl pyridine, triethanolamine, ethylene diamine tetra-acetic acid, an alkylated diethylene triamine, or a dialkylaminoalkyl acrylate or methacrylate. The amine may be a polymer e.g. a dialkyl aminoalkyl cellulose, a polyvinyl pyridine, an alkylated polyethyleneimine, a condensation product of a dibasic carboxylic acid with a polyalkylene polyamine (for example adipic acid with diethylene triamine treated with an alkylating agent such as dimethyl sulphate or a cross-linking agent such as epichlorhydrin) or a polymer derived from a dialkyl aminoalkyl acrylate or methacrylate or acrylamide. The alkyl groups contain 1-8 carbon atoms, preferably 1-4. Dialkyl thionocarbamates may be used as collectors at a pH of 8-12, using methyl isobutyl carbinol, pine oil, or polypropylene oxides as frothing agents. The process may be used during flotation of sulphide minerals from ore, and during separation of metal values from the "bulk sulphides" so produced. Other depressants may be used at the same time, e.g. soluble silicates, lignosulphonates, and cyanide salts. If desired, the pyrites or pyrrhotite together with sphalerite may be depressed, and the sphalerite subsequently floated in the presence of an activator therefor, e.g. copper sulphate or lead nitrate. Examples are given of beneficiation of copper, zinc, lead, and nickel bearing ores in two or three stages.
Patent IE-50638-B1 (IE)
Title: Antibiotic compositions
IPC: A23K20/195
Filed: 1980-12-23
Abstract: Antibiotic compositions comprising certain novel combinations of macrolide and aminoglycoside antibiotics or their physiologically acceptable salts have been found particularly effective in the treatment of colibacillosis in pigs. They are also of value as growth promoters and in improving the feed utilization in pigs. They are also valuable in controlling the growth of mycoplasma in mammalian tissue cultures.
Patent IE-52163-B1 (IE)
Title: Method of controlling operation of an electrostatic precipitator
IPC: B03C3/68
Filed: 1981-12-08
Abstract: The invention relates to the method of controlling the operating parameters of an electrostatic precipitator which is energised by voltage pulses superimposed on a DC-voltage. The pulse height is continuously increased linearly with time and spark overs are detected as reductions in the precipitator voltage below a selectable set value and are sorted into different types according to the time of their occurrence and their duration. According to the type of spark-over detected so the operating parameters of the filter are modified accordingly.
Patent IE-67656-B1 (IE)
Title: Immunostimulating 6-aryl-5,6-dihydroimidazo[2,1-b]thiazole derivatives
Inventor: RAEYMAEKERS ALFONS HERMAN MARGARETHA
IPC: A61P37/04
Filed: 1990-11-23
Abstract: Novel 6-aryl-5,6-dihydroimidazo[2,1-b]thiazole derivatives of formula   <CHEM>  wherein Ar is phenyl optionally substituted with halo, hydroxy, C1-6alkyloxy, mercapto, C1-6alkylthio, C1-6alkyl, nitro, amino, mono- and di(C1-6alkyl)amino, C1-6alkylcarbonylamino, arylcarbonylamino, C1-6alkylsulfonylamino, trifluoromethyl, cyano, aminocarbonyl, mono- and di(C1-6alkyl)aminocarbonyl, hydroxycarbonyl, C1-6alkyloxycarbonyl, carboxaldehyde or hydroxymethyl; pyridinyl; thienyl; furanyl or furanyl substituted with either C1-6alkyl or halo; R<1> and R<2> are C1-20alkyl, (C3-7cycloalkyl)C1-6alkyl, C3-7cycloalkyl, aryl or (aryl)C1-6alkyl; one of R<1> and R<2> may by hydrogen; or R<1> and R<2> taken together may form a C3-6alkanediyl radical; the acid addition salts and stereochemically isomeric forms thereof, said compounds having immunostimulating properties. Pharmaceutical compositions containing such compounds as active ingredient. Processes of preparing said novel compounds and pharmaceutical compositions.
Patent IE-70235-B1 (IE)
Title: Expanding plug
Inventor: BISPING HEINZ
IPC: F16B13/14
Filed: 1992-07-01
Abstract: The expanding plug (1) with an expanding part (2) has two diametrically opposite, axially open longitudinal slots (6a, 6b) which are offset through 90 DEG in the circumferential direction with respect to two diametrically opposite, axially closed longitudinal slots (5a, 5b). The axially closed longitudinal slots (5a, 5b) and the axially open longitudinal slots (6a, 6b) partially overlap axially, so that the expanding part (2) can be expanded in the overlapping region without the expanding element (3), which is used for expansion, moving.
Patent IE-67182-B1 (IE)
Title: Cleaning compositions
Inventor: JEFFEY GARETH CHARLES
IPC: H05K3/26
Filed: 1992-07-17
Abstract: This invention relates to a composition for cleaning contaminated electronic substrates. The compossition comprises a blend of 2-30% w/w of ethoxyethoxy ethanol and at least one other glycol ether derivative selected from butoxyethoxy ethanol, methoxypropoxy propanol, ethoxypropoxy propanol and C1-C5 monocarboxylic acid esters thereof. These esters are more environmentally safe and more user friendly than halohydrocarbons used hitherto for cleaning fluxes and solders from circuit boards.
Patent LU-500638-B1 (LU)
Title: Method for improving resistance of tobacco to phytophthora nicotianae infection
Inventor: GUO LIN
IPC: A01N43/02
Filed: 2021-09-09
Granted: 2022-03-09
Abstract: The present invention provides a method for improving resistance of tobacco to Phytophthora nicotianae infection, and belongs to the field of gene engineering. According to the present invention, a Phytophthora-nicotianae-resistant plant is obtained by means of a transgenic technology, the activity of defense enzymes in the tobacco is improved, the resistance of the tobacco to the Phytophthora nicotianae is enhanced, and without affecting growth of the tobacco, the method improves drought resistance and salt tolerance of the tobacco, greatly reduces consumption of pesticides and reduces the environmental pollution.
Patent NO-307912-B1 (NO)
Inventor: LUDWIG GEORG-WILHELM
IPC: A01P1/00
Filed: 1992-04-07
Abstract: Novel synergistic microbicidal active substance combinations and their use, consisting of an azole fungicide such as tebuconazole and an iodopropargyl derivative such as IPBC, if appropriate with an addition of further active compounds.
Patent NO-301450-B1 (NO)
Inventor: DARBONNE LUC
IPC: A23L27/14
Filed: 1992-04-07
Abstract: Apparatus for the preparation of deep-frozen vegetables, comprising, from upstream to downstream, a device (10) for washing fresh vegetables and a device (14) for drying washed vegetables; the device (16) for individual and rapid type deep freezing; at least one device (22) suitable for applying to the deep-frozen vegetables mechanical constraints which are sufficient to enable them to be broken into several pieces; at least one device (23) for sorting the homogeneous deep-frozen pieces; a device (30) for packaging at least one of the deep-frozen pieces; means for discharging the piece or pieces emerging from the sorting device and not intended for use; 
<??>This apparatus being specially adapted to the preparation of herbs or aromatic plants. 
<IMAGE>
Patent NO-315409-B1 (NO)
Inventor: MALEFYT RENE DE WAAL
IPC: A61P31/04
Filed: 1994-02-04
Abstract: A method is provided for treating septic shock or toxic shock that comprises administering an effective amount of interleukin-10.
Patent NO-313549-B1 (NO)
Inventor: BORGHOLM HANS ERIK
IPC: C04B7/00
Filed: 1994-10-12
Abstract: PCT No. PCT/DK93/00132 Sec. 371 Date Jan. 4, 1995 Sec. 102(e) Date Jan. 4, 1995 PCT Filed Apr. 13, 1993 PCT Pub. No. WO93/21122 PCT Pub. Date Oct. 28, 1993A cement composition consists essentially of (a) from 50% to 97% by weight (calculated on the total composition) of a Portland cement clinker, the sulfur content of which is from 0.5% to 10% by weight expressed as SO3 and the fluorine content of which is from 0.13% to 1.00% by weight expressed as F, and (b) from 3% to 50% by weight (calculated on the total composition) of an extender containing a carbonate selected from calcium carbonate, magnesium carbonate, calcium magnesium carbonate and mixtures thereof as its main constituent and having a median particle size (d50) of below 14  mu m. Preferably, the total content of C3S and C2S in the Portland cement clinker is at least 65%. A preferred carbonate is electrostatic precipitator dust extracted from cement kiln exhaust gases. The cement composition may be mixed with further components such as other extenders, retarding agents and aggregate.
Patent NO-311473-B1 (NO)
Inventor: DEKKER ANDRE
IPC: H03G3/30
Filed: 1995-05-05
Abstract: PCT No. PCT/FI94/00393 Sec. 371 Date May 2, 1995 Sec. 102(e) Date May 2, 1995 PCT Filed Sep. 5, 1994 PCT Pub. No. WO95/07573 PCT Pub. Date Mar. 16, 1995An arrangement for controlling the operation of a high-frequency power amplifier includes a high-frequency power amplifier connected to a forward line and a control, and an attenuator connected to the input side thereof. A sampler and a detector are connected to a feedback line between the output side and the input side of the high-frequency power amplifier. An amplifier is connected to the feedback line on the input side of the detector, the gain of the latter amplifier being of the same order of magnitude as the attenuation provided by the attenuator.
Patent NO-309029-B1 (NO)
Inventor: MIKATS GUENTHER
IPC: B29C48/154
Filed: 1995-09-27
Abstract: PCT No. PCT/AT95/00016 Sec. 371 Date Sep. 20, 1995 Sec. 102(e) Date Sep. 20, 1995 PCT Filed Jan. 27, 1995 PCT Pub. No. WO95/20481 PCT Pub. Date Aug. 3, 1995A process and device are disclosed for producing glass fiber mat reinforced thermoplastic boards, as well as their advantageous use. Glass fiber mats are impregnated with molten thermoplastics and the composite glass fiber mat is then pressed. At least one of the glass fiber mats runs through the aperture of an impregnation nozzle controllably supplied with molten thermoplastics by extruders, forming two streams of molten mass that are applied at the outlet of the nozzle aperture on the top and on the bottom of the glass mats, pre-impregnating the glass fiber mat. These glass fiber mats thus pre-impregnated with thermoplastics runs through a gap between feeding rollers of a double belt press, are pre-calibrated then pressed by cooling plates into glass fiber mat reinforced thermoplastic board.
Patent NO-322186-B1 (NO)
Inventor: DORNER FRIEDRICH
IPC: A61K35/16
Filed: 1997-01-07
Abstract: The invention relates to a medicament containing one or more plasma derivatives as the active or auxiliary agent, in which the basic material or the intermediate products arising during the production of the plasma derivatives exert no viral stress on one or more differently proliferable haematogenic viruses or such an effect not exceeding a defined limit. The basic material or intermediate product for producing the final plasma derivative of which the quality is thus assured is subsequently subjected to at least one essential viral enrichment or inactivation step. The invention also describes a process for producing the medicament and the production of assured-quality basic materials or intermediate products.
Patent NO-315562-B1 (NO)
Inventor: BALLARD MATHEW JOHN
IPC: C08F2/44
Filed: 1997-03-07
Abstract: The present invention relates to a process for producing polymer beads incorporating solid particles and to the novel polymer beads per se. The invention provides a process for producing polymer beads incorporating solid particulate material, which process comprises producing a dispersion having a dispersed phase including one or more monomers also including solid particulate material, and causing said one or more monomers to undergo a polymerisation reaction to form said polymer beads, wherein said dispersion further includes a solid phase dispersing agent for dispersing solid particles of material in the dispersed phase and wherein said solid phase dispersing agent reacts with at least one monomer to thereby become chemically incorporated in said polymer. The polymer beads comprise a polymer matrix having solid particulate material dispersed substantially uniformly therein and wherein the polymer matrix incorporates a solid phase dispersing agent chemically reacted into the polymeric matrix.
Patent NO-319281-B1 (NO)
Inventor: KAMEN DEAN L
IPC: A61G5/06
Filed: 1997-07-08
Abstract: There is provided, in a preferred embodiment, a transportation vehicle for transporting an individual over ground having a surface that may be irregular. This embodiment has a support for supporting the subject. A. ground-contacting module, movably attached to the support, serves to suspend the subject in the support over the surface. The orientation of the ground-contacting module defines fore-aft and lateral planes intersecting one another at a vertical. The support and the ground-contacting module are components of an assembly. A motorized drive, mounted to the assembly and coupled to the ground-contacting module, causes locomotion of the assembly and the subject therewith over the surface. Finally, the embodiment has a control loop, in which the motorized drive is included, for dynamically enhancing stability in the fore-aft plane by operation of the motorized drive in connection with the ground-contacting module. Included in the control loop is a directional control, letting the vehicle move, lean and turn in response to an indication of the subject, e.g. that of leaning the vehicle. The ground contacting module may be realized as a pair of ground-contacting members, laterally disposed with respect to one another. The ground-contacting members may be wheels, a duster of wheels, or includes rotatably mounted arcuate element pairs.
Patent NO-323970-B1 (NO)
Inventor: KARI HANNU H
IPC: H04B7/26
Filed: 1997-07-09
Abstract: PCT No. PCT/FI96/00019 Sec. 371 Date Jul. 9, 1997 Sec. 102(e) Date Jul. 9, 1997 PCT Filed Jan. 8, 1996 PCT Pub. No. WO96/21983 PCT Pub. Date Jul. 18, 1997The present invention relates to a protocol-independent routing of data packets between a mobile station of a packet radio network and a party(Host) connected to an external network. In the invention, a data packet of an extraneous protocol(IPX) is transferred through a packet radio network using a second protocol as encapsulated in a data packet according to the second protocol. The transferring packet radio network does not thus need to understand the protocol of the transferred extraneous data packet or to be able to interpret the content of the data packet. A data packet network is connected to other packet radio networks, data networks or the backbone network between packet data networks via a gateway node(GPRS GSN), which uses the network-internal protocol towards the dedicated packet network and the protocol of each network towards other networks. When a data packet is transferred via a gateway node from a network into another network, the data packet is encapsulated in a packet according to the protocol of the new network. When the encapsulated data packet arrives in a node which supports the protocol of the encapsulated data packet, the encapsulation is stripped away and the data packet is routed forward according to the protocol of the data packet.